Shares of Regeneron Pharmaceuticals Inc. REGN advanced 5.25% to $598.76 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX ...

73 analyst firms have reported ratings in the last year. The last upgrade for Regeneron Pharmaceuticals Inc happened on May 14, 2025 when Citigroup raised their price target to $700. Citigroup ...

The Regeneron Pharmaceuticals Inc.-Bond has a maturity date of 9/15/2050 and offers a coupon of 2.8000%. The payment of the coupon will take place 2,0 times per biannual on the 15.03.. At the ...